| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 21, 2025 | Tax withholding(F) | 20K | $1.15 | $23K | 2.2M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-001900) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Acrivon Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.